Key result
Coronary heart disease patients had lower gut Bacteroidetes and higher Firmicutes than healthy controls.
Case-Control (n=64)
Answers are grounded in this paper and cite their sources.
Objectives. We aimed to explore the impact of gut microbiota in coronary heart disease (CHD) patients through high-throughput sequencing. Methods. A total of 29 CHD in-hospital patients and 35 healthy volunteers as controls were included. Nucleic acids were extracted from fecal samples, followed by α diversity and principal coordinate analysis (PCoA). Based on unweighted UniFrac distance matrices, unweighted-pair group method with arithmetic mean (UPGMA) trees were created. Results. After data optimization, an average of121312±19293reads in CHD patients and234372±108725reads in controls was obtained. Reads corresponding to 38 phyla, 90 classes, and 584 genera were detected in CHD patients, whereas 40 phyla, 99 classes, and 775 genera were detected in controls. The proportion of phylum Bacteroidetes (56.12%) was lower and that of phylum Firmicutes was higher (37.06%) in CHD patients than those in the controls (60.92% and 32.06%,P<0.05). PCoA and UPGMA tree analysis showed that there were significant differences of gut microbial compositions between the two groups. Conclusion. The diversity and compositions of gut flora were different between CHD patients and healthy controls. The incidence of CHD might be associated with the alteration of gut microbiota.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2017) conducted a case-control in Coronary heart disease (n=64). Coronary heart disease (gut microbiota composition) vs. Healthy volunteers was evaluated on Proportion of phylum Bacteroidetes in gut microbiota (p=<0.05). Coronary heart disease patients had lower gut Bacteroidetes and higher Firmicutes than healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: